Search Results - "Palmu, Arto"

Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a nationwide cohort study by Baum, Ulrike, Poukka, Eero, Palmu, Arto A, Salo, Heini, Lehtonen, Toni O, Leino, Tuija

“…Background In Finland, both mRNA and adenovirus vector (AdV) Covid-19 vaccines have been used after the vaccination campaign started on December 27, 2020…”
Get full text

Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study by Jokinen, Jukka, Rinta-Kokko, Hanna, Siira, Lotta, Palmu, Arto A, Virtanen, Mikko J, Nohynek, Hanna, Virolainen-Julkunen, Anni, Toropainen, Maija, Nuorti, J Pekka

“…The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 with a 2+1 schedule…”
Get full text

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans by Haveri, Anu, Ekström, Nina, Solastie, Anna, Virta, Camilla, Österlund, Pamela, Isosaari, Elina, Nohynek, Hanna, Palmu, Arto A, Melin, Merit

“…Most subjects develop antibodies to SARS‐CoV‐2 following infection. In order to estimate the duration of immunity induced by SARS‐CoV‐2 it is important to…”
Get full text

Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 by Poukka, Eero, Baum, Ulrike, Palmu, Arto A., Lehtonen, Toni O., Salo, Heini, Nohynek, Hanna, Leino, Tuija

“…Recently, Covid-19 vaccine effectiveness has decreased especially against mild disease due to emergence of the Delta variant and waning protection. In this…”
Get full text

Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects by Haveri, Anu, Solastie, Anna, Ekström, Nina, Österlund, Pamela, Nohynek, Hanna, Nieminen, Tuomo, Palmu, Arto A., Melin, Merit

“…The emergence of SARS‐CoV‐2 Omicron variant (B.1.1.529) with major spike protein mutations has raised concern over potential neutralization escape and…”
Get full text

Time and labour costs of preventive health care, including vaccinations, in Finnish child health clinics by Nieminen, Heta, Hakulinen, Tuovi, Puumalainen, Taneli, Sirén, Päivi, Palmu, Arto A

“…In Finland all children are entitled to regular health check-up visits at child health clinics (CHC). During the visits public health nurses and physicians…”
Get full text

High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron by Baum, Ulrike, Poukka, Eero, Leino, Tuija, Kilpi, Terhi, Nohynek, Hanna, Palmu, Arto A

“…Abstract Background The elderly are highly vulnerable to severe COVID-19. Waning immunity and emergence of Omicron have caused concerns about reduced…”
Get full text

Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial by Rinta-Kokko, Hanna, Palmu, Arto A, Ruokokoski, Esa, Nieminen, Heta, Moreira, Marta, Schuerman, Lode, Borys, Dorota, Jokinen, Jukka

“…In the nation-wide double-blind cluster-randomised Finnish Invasive Pneumococcal disease trial (FinIP, ClinicalTrials.gov NCT00861380, NCT00839254), we…”
Get full text

Incidence of sinus thrombosis with thrombocytopenia-A nation-wide register study by Hovi, Petteri, Palmu, Arto A, Nieminen, Tuomo A, Artama, Miia, Jokinen, Jukka, Ruokokoski, Esa, Lassila, Riitta, Nohynek, Hanna, Kilpi, Terhi

“…Safe vaccination is essential for mitigation of the COVID-19 pandemic. Two adenoviral vector vaccines, ChAdOx1 nCov-19 (AstraZeneca) and Ad26.COV2.S…”
Get full text

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial by Palmu, Arto A, Dr, Jokinen, Jukka, PhD, Borys, Dorota, MD, Nieminen, Heta, MD, Ruokokoski, Esa, MSc, Siira, Lotta, MSc, Puumalainen, Taneli, MD, Lommel, Patricia, MSc, Hezareh, Marjan, PhD, Moreira, Marta, MD, Schuerman, Lode, MD, Kilpi, Terhi M, MD

“…Summary Background The Finnish Invasive Pneumococcal disease (FinIP) vaccine trial was designed to assess the effectiveness of a pneumococcal vaccine…”
Get full text

Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study by Palmu, Arto A, Rinta-Kokko, Hanna, Nohynek, Hanna, Nuorti, J Pekka, Kilpi, Terhi M, Jokinen, Jukka

“…The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 using a 2+1 schedule…”
Get full text

Culture of all sputum samples irrespective of quality adds value to the diagnosis of pneumococcal community-acquired pneumonia in the elderly by Saukkoriipi, Annika, Palmu, Arto A., Jokinen, Jukka

“…Culture of expectorated sputum in the microbiological diagnosis of community-acquired pneumonia (CAP) is considered valid only if high-quality (HQ) samples are…”
Get full text

Effectiveness of trivalent influenza vaccines against hospitalizations due to laboratory-confirmed influenza a in the elderly: Comparison of test-negative design with register-based designs by Halme, Jussi, Syrjänen, Ritva K., Baum, Ulrike, Palmu, Arto A.

“…•We compared test-negative and register-based designs in estimating influenza VE.•Influenza VE estimates for all designs and analyses tended to be quite…”
Get full text

Lower incidence of hospital-treated infections in infants under 3 months of age vaccinated with BCG by Nieminen, Heta, Lahdenkari, Mika, Syrjänen, Ritva K., Nohynek, Hanna, Ruokokoski, Esa, Palmu, Arto A.

“…•A natural experiment was used to study the non-specific effects of BCG.•Outcomes included all infections and injuries recorded in nation-wide…”
Get full text

Early Vaccine-type Pneumococcal Acute Otitis Media Does not Predispose to Subsequent Otitis When Compared With Early Acute Otitis Media Due to Other Bacterial Etiology by Palmu, Arto A, Lahdenkari, Mika

“…BACKGROUND:Prevention of acute otitis media (AOM), and especially recurrence and biofilm formation, by pneumococcal conjugate vaccines has been hypothesized to…”
Get full text

Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland by Polkowska, Aleksandra, Rinta-Kokko, Hanna, Toropainen, Maija, Palmu, Arto A., Nuorti, J. Pekka

“…No previous studies have reported long-term follow-up of ten-valent pneumococcal conjugate vaccine (PCV10) program impact on pneumococcal meningitis (PM). We…”
Get full text

Re: “First Otitis Media and Pneumococcal Conjugate Vaccine Serotypes in Infants” by Palmu, Arto A, Lahdenkari, Mika

Get full text

Underreporting of SARS-CoV-2 infections during the first wave of the 2020 COVID-19 epidemic in Finland-Bayesian inference based on a series of serological surveys by Nieminen, Tuomo A, Auranen, Kari, Kulathinal, Sangita, Härkänen, Tommi, Melin, Merit, Palmu, Arto A, Jokinen, Jukka

“…In Finland, the first wave of the COVID-19 epidemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) took place from March to June…”
Get full text

Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland by Rinta-Kokko, Hanna, Palmu, Arto A., Auranen, Kari, Nuorti, J. Pekka, Toropainen, Maija, Siira, Lotta, Virtanen, Mikko J., Nohynek, Hanna, Jokinen, Jukka

“…•The net impact of PCV10 remains high in the vaccine-eligible cohort six years after implementation.•PCV10 offers long-lasting direct cross-protection against…”
Get full text

A retrospective nationwide register-based study to evaluate the non-specific effects of first MMR vaccination among children in Finland by Palmu, Akseli A.M., Nieminen, Heta, Lahdenkari, Mika, Palmu, Arto A.

“…•The recommended age of MMR vaccination changed in 2011 creating a natural experiment.•We observed no non-specific effect on all-cause infections due to MMR…”
Get full text